Pei Liu

Pei Liu

Auto-generated profile, based on publicly available information

Pei Liu

The First Hospital of Qinhuangdao, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
YYYunyao Ye
Yunyao Ye
JGJingyao Gu
Jingyao Gu
PLPei Liu
Pei Liu
HWHe Wang
He Wang
LJLihua Jiang
Lihua Jiang
ZWZhaoxia Wang
Zhaoxia Wang
Purpose: Long non-coding RNA (lncRNA) SPRY4 intronic transcript 1 (SPRY4-IT1) is reported to play important roles in the occurrence and development of many tumors. However, the possible role of SPRY4-IT1 in cisplatin (DDP) resistance of non-small-cell lung cancer (NSCLC) remains unclear. The aim of this study is to investigate the functions and molecular mechanisms underlying SPRY4-IT1 of cisplatin resistance in NSCLC. Methods: Expression of SPRY4-IT1 was analyzed in A549 and cisplatin-resistant A549/DDP cell lines by quantitative real-time polymerase chain reaction (RT-qPCR). Overexpression techniques were applied to investigate the biological functions of SPRY4-IT1 in cisplatin-resistant A549/DDP cells. The effects of SPRY4-IT1 on proliferation and apoptosis were evaluated using cell counting kit-8 (CCK8) assays, colony formation assay and flow-cytometric analysis. The expressions of epithelial–mesenchymal transition (EMT)-associated proteins, including E-cadherin and Vimentin, were detected by Western blot. Microarray analysis was performed to identify the putative targets of SPRY4-IT1, which were further verified by Western blotting and RT-qPCR. A549/DDP cells transfected with pCDNA-SPRY4-IT1 were injected into nude mice in order to verify the effect of SPRY4-IT1 on cisplatin resistance in vivo. Results: The present study demonstrated that SPRY4-IT1 expression was decreased in A549/DDP cells compared with parental A549 cells. Upregulation of SPRY4-IT1 suppressed cell proliferation and caused apoptosis of A549/DDP cells both in vitro and in vivo. MPZL-1 was negatively regulated by SPRY4-IT1. Furthermore, upregulation of SPRY4-IT1 and downregulation of MPZL-1 could suppress epithelial–mesenchymal transition (EMT), which was characterized by increased E-cadherin expression and decreased Vimentin expression. Conclusion: Upregulation of SPRY4-IT1 reversed the cisplatin-resistant phenotype of NSCLC partially by downregulating MPZL-1 via inhibiting EMT process.

26 November 2022 in Cancer Genetics
Verified
Journal Article
Closed access
JBJeffrey Bryan
Jeffrey Bryan
ZSZachary Skidmore
Zachary Skidmore
HRHansjorg Rindt
Hansjorg Rindt
SCShirley Chu
Shirley Chu
BFBrian Fisk
Brian Fisk
OGObi L. Griffith
Obi L. Griffith

3 September 2023 in Archives of Medical Science
Verified
Journal Article
Open access
LPLiu Pei
Liu Pei
ZZZhigang Zuo
Zhigang Zuo
MZMeixiang Zhang
Meixiang Zhang
LZLikun Zhao
Likun Zhao
KLKaishuang Li
Kaishuang Li
Introduction: Antimicrobial peptides (AMPs) are endogenous peptides that have been identified to alleviate intestinal epithelial barrier inflammation and dysfunction caused by enteropathogenic Escherichia coli (EPEC) infection; nonetheless, the upstream molecular mechanism of the production of...